Trial intelligence / Profile preview

Albendazole for Diarrhea Prevention in Vietnamese School Children

NCT02597556Phase 4Withdrawn

Sponsor
Oxford University Clinical Research Unit
Start
Feb 2016
Primary completion
May 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of albendazole in intestinal helminthiasis, diarrhea, sponsored by Oxford University Clinical Research Unit. Planned start Feb 2016; status: withdrawn.

02

Drugs

albendazole
03

Conditions

intestinal helminthiasisdiarrhea

Beyond the preview

Go deeper on NCT02597556.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02597556.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call